购物车
您的购物车当前为空
KIN1400, a novel IRF3 activator, triggers IRF3-dependent innate immune antiviral genes and IFNbeta307 expression, suppresses WNV, DV infection, and HCV replication.
KIN1400, a novel IRF3 activator, triggers IRF3-dependent innate immune antiviral genes and IFNbeta307 expression, suppresses WNV, DV infection, and HCV replication.

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 2,390 | 35日内发货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | KIN1400, a novel IRF3 activator, triggers IRF3-dependent innate immune antiviral genes and IFNbeta307 expression, suppresses WNV, DV infection, and HCV replication. |
| 分子量 | 449.47 |
| 分子式 | C24H17F2N3O2S |
| CAS No. | 446826-86-4 |
| Smiles | C(NC1=NC=2C(S1)=CC=CC2)(C3=C(O)C4=C(C=C3)C=CC=N4)C5=CC=C(OC(F)F)C=C5 |
| 密度 | 1.443 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多